Insmed (INSM) Debt to Equity (2012 - 2026)

Insmed's Debt to Equity history runs 15 years deep, the most recent figure standing at $0.77 for Q1 2026.

• In Q1 2026, Debt to Equity fell 93.1% year-over-year to $0.77; the TTM figure through Mar 2026 stood at $0.77 (down 93.1% YoY), while the FY2025 annual figure was $0.73, down 81.07% from the prior year.
• Debt to Equity was $0.77 for Q1 2026 at Insmed, up from $0.73 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $30.17 in Q2 2024 to a low of -$26.2 in Q3 2022.
• Historically, Debt to Equity has averaged $1.05 across 5 years, with a median of $0.73 in 2025.
• Biggest YoY gain for Debt to Equity was 1614.93% in 2022; the steepest drop was 2471.71% in 2022.
• A 5-year view of Debt to Equity shows it stood at $12.79 in 2022, then plunged by 127.21% to -$3.48 in 2023, then surged by 211.08% to $3.87 in 2024, then plunged by 81.07% to $0.73 in 2025, then climbed by 5.08% to $0.77 in 2026.
• The last three Debt to Equity figures came in at $0.77 (Q1 2026), $0.73 (Q4 2025), and $0.57 (Q3 2025), per Business Quant data.